Holdco Nuvo Group D.G Ltd logo

Holdco Nuvo Group D.G Ltd (NUVOQ)

Market Closed
14 Aug, 20:00
OTC PINK OTC PINK
$
0. 01
-0
-7.6923%
$
- Market Cap
- P/E Ratio
- Div Yield
100 Volume
0 Eps
$ 0.01
Previous Close
Add Transaction
Day Range
0.01 0.01
Year Range
0 0.3
Want to track NUVOQ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

NUVOQ closed Friday lower at $0.01, a decrease of -7.6923% from Thursday's close, completing a monthly decrease of -40.8072% or -$0.01. Over the past 12 months, NUVOQ stock gained 13,100.0004%.
NUVOQ is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

NUVOQ Chart

Holdco Nuvo Group D.G Ltd (NUVOQ) FAQ

What is the stock price today?

The current price is $0.01.

On which exchange is it traded?

Holdco Nuvo Group D.G Ltd is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is NUVOQ.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Holdco Nuvo Group D.G Ltd ever had a stock split?

No, there has never been a stock split.

Holdco Nuvo Group D.G Ltd Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Robert Maurice Powell Jr. CEO
OTC PINK Exchange
IL0012023656 ISIN
IL Country
- Employees
- Last Dividend
- Last Split
2 May 2024 IPO Date

Overview

Holdco Nuvo Group D.G Ltd, previously known as Nuvo Group Ltd., is an innovative company focusing on the development and marketing of advanced medical devices for pregnancy monitoring. With operations spanning Israel, the United States, and other international markets, Holdco Nuvo Group has positioned itself as a pioneer in offering remote pregnancy monitoring solutions. The company offers the INVU platform, a groundbreaking self-administered wireless sensory band designed for expectant mothers, allowing them and their obstetricians to monitor both maternal and fetal heart rates, as well as maternal uterine activity, from the comfort of their home or in a clinic setting starting from the 32nd week of pregnancy until labor commences. Holdco Nuvo Group D.G Ltd has established collaborative efforts with esteemed institutions like Royal Philips and Charité – Universitätsmedizin Berlin, underlining its commitment to excellence and innovation in the field. Founded in 2006 and based out of Tel Aviv, Israel, the company underwent a name change in May 2024. However, on August 22, 2024, Holdco Nuvo Group faced a significant challenge by filing a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware, marking a pivotal moment in its journey.

Products and Services

  • INVU Platform

    The INVU platform stands at the heart of Holdco Nuvo Group's product offering. This innovative service is a self-administered, remote pregnancy monitoring platform that makes use of a wireless sensory band. This band, designed with expectant mothers in mind, enables a new level of engagement in prenatal care by allowing continuous monitoring of both maternal and fetal heart rates in addition to maternal uterine activity. Starting from the 32nd week of pregnancy up to the onset of labor, the INVU platform provides a technological leap in prenatal care. This platform comprises:

    • A wireless sensory band equipped with multi-modality technology to accurately capture necessary signals.
    • A sophisticated cloud computing environment designed for processing and analyzing captured data.
    • Personalized reports on maternal and fetal health metrics, delivered directly to the expectant mother and her obstetrician through advanced digital visualization tools.

    This comprehensive system not only promotes enhanced prenatal care but also fosters a closer connection between pregnant women and their healthcare providers, facilitating shared knowledge and reassurance throughout the pregnancy journey.

Contact Information

Address: Alon Tower 1, Tel Aviv, Israel, 6789155
Phone: 972 3 624 2266